Tue 18'th Sep 2018
Edge Therapeutics Stock Analysis
Technical stock analysis for Tue 18'th Sep 2018
|Shorts||7.65% ( 2018-08-31 )|
Edge Therapeutics fell by -8.00% in the last day from $0.76 to $0.70 and has now fallen 3 days in a row. The price has fallen in 8 of the last 10 days and is down by -18.12% for this period. Volume has increased in the last day by 311 236 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 430 302 shares bought and sold for approximately $301 254.00.
Edge Therapeutics has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($0.72) are considered to be a "second chance" to get out. According to the fan-theory $0.59 will represent the new bottom line of the next trend, but it is far too early to say this for certain.
There are few to none technical positive signals at the moment. Edge Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.79 and $0.87. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday September 07, 2018, which indicates further falls until a new bottom pivot has been found. Edge Therapeutics gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
The stock currently holds a RSI14 at 28 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.08 between high and low, or 11.40%. For the last week, the stock has had a daily average volatility of 8.23%.
Edge Therapeutics is oversold on RSI14 (28). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Edge Therapeutics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.Click for Top 5 Strong Sell Candidates
|EDGE $0.70 $-0.06(-8.00%)|
EDGE is down $0.06 today, but where's it headed in October?
|Zacks Investment Research is releasing its prediction for EDGE based on the 1-3 month system that more than doubles the S&P 500.
Click here – the EDGE analysis is free »